18.06.2013 Views

Bio - NCH Healthcare System

Bio - NCH Healthcare System

Bio - NCH Healthcare System

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Michael Scott Flynn, M.D., F.A.C.C., F.S.C.A.I. November 2011<br />

PROFESSIONAL SOCIETIES<br />

o Fellow, American College of Cardiology (1994)<br />

o Member Echo Task Force, FCACC 2008<br />

o Fellow, Society for Cardiac Angiography and Interventions (1994)<br />

o Member, Collier County Medical Society (1994)<br />

o Member, Florida Medical Association (1994)<br />

o Mended Hearts, Inc. Lifetime Member<br />

OTHER INTERESTS<br />

o Member, Par Club, Western Golf Association (WGA) 1986 - Present<br />

RESEARCH (1992-1994)<br />

1. Kern MJ, Aguirre FV, Chaitman BR, Bach R, Donohue TJ, Flynn MS, Labovitz AJ, Miller LW. The<br />

graft study (Graft Reperfusion After Thrombolysis): A randomized trial of urokinase and t-PA for<br />

intragraft thrombus and myocardial ischemia: A multicenter trial.<br />

2. Kern M J, Aguirre F V, Bach R , D onohue TJ, Wolford T, P enick D , Flynn MS, L abovitz AJ. A<br />

double-blind parallel comparison of the effects of intravenous ranolazine versus placebo on indices<br />

of ischemia in patients undergoing coronary angioplasty.<br />

3. Kern MJ, Aguirre FV, Bach R, Donohue TJ, Flynn MS. Intracoronary stenting for acute occlusion<br />

after coronary balloon angioplasty and as a primary treatment for coronary occlusive disease.<br />

4. Cohen JC, Flynn MS, Loyet A. A randomized, placebo-controlled double-blind parallel study of the<br />

safety and antihypertensive efficacy of losartan monotherapy as compared to HCTZ monotherapy<br />

and the combination of losartan and HCTZ in patients with mild to moderate hypertension.<br />

5. Cohen J C, Flynn MS. T he e ffect o f oral D -sotalol on m ortality in p atients with a therosclerotic<br />

coronary heart disease and left ventricular dysfunction "SWORD."<br />

6. Kern MJ, Donohue T, Bach R, Aguirre F, Caracciolo E, Wolford T, Flynn MS, Al-Joundi B, Johnson<br />

R, Dincer B, Serota H, Reese J, Mechem CJ, Stonner T, Cauley M, Abbott L. Velocity assessment<br />

for lesions of indeterminate severity "VALID."<br />

7. Kern MJ, Donohue T, Bach R, Aguirre F, Caracciolo E, Wolford T, Flynn MS, Al-Joundi B, Johnson<br />

R, D incer B , Serota H , R eese J , M echem C J, Stonner T, C auley M , Abbott L. A r andomized,<br />

open-label, parallel study to evaluate the effects of fluosol on complications, duration of hospital<br />

stay and l eft v entricular function i n coronary angioplasty p atients a t hi gh r isk of hemodynamic<br />

deterioration.<br />

8. Kern MJ, Donohue T, Bach R, Aguirre F, Caracciolo E, Wolford T, Flynn MS, Al-Joundi B, Johnson<br />

R, Dincer B, Serota H, Reese J, Mechem CJ, Stonner T, Cauley M, Abbott L. Simvastatin coronary<br />

vasoreactivity trial.<br />

9. Chaitman BR, Aguirre FV, Flynn MS, Kern M, Wiens RD, Labovitz AJ, Lewis L, Quick G, Chang L,<br />

Brooks C , F ortney J , R uoff B, N aunheim R. Thrombolysis an d t hrombin i nhibition in ac ute<br />

myocardial infarction - TIMI 9 (CGP 39393, IND #34046).<br />

4

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!